Differential Expression of microRNAs in Urinary Extracellular Vesicles Obtained From Hypertensive Patients  Soon Hyo Kwon, MD, Hui Tang, PhD, Ahmed Saad,

Slides:



Advertisements
Similar presentations
The Rise of Renal Pathology in Nephrology: Structure Illuminates Function Vivette D. D'Agati, MD, Michael Mengel, MD American Journal of Kidney Diseases.
Advertisements

Fredrik Karlsson, MD, Angelo Modica, MD, Thomas Mooe, MD, PhD 
Recent Advances in Traditional Chinese Medicine for Kidney Disease
Renal Function Testing
Peritoneal dialysis American Journal of Kidney Diseases
Olivier Niel, MD, PhD, Charlotte Boussard, MSc, Paul Bastard, MSc 
Hypertension in the hemodialysis patient and the “lag phenomenon”: insights into pathophysiology and clinical management  Uday M Khosla, MD, Richard J.
Jessica W. Weiss, MD, Eric S. Johnson, PhD, Amanda Petrik, MS, David H
Quiz Page March 2008 American Journal of Kidney Diseases
Dorian Schatell, MS, Meg Wise, PhD, Kristi Klicko, CHES, Bryan N
Surviving the First Year of Peritoneal Dialysis: Enduring Hard Times
Amir Said Alizadeh Naderi, MD, Biff F. Palmer, MD 
Quiz Page December 2007 American Journal of Kidney Diseases
Dialysis Facility Ownership and Epoetin Dosing in Hemodialysis Patients: A Dialysis Provider’s Perspective  J. Michael Lazarus, MD, Raymond M. Hakim,
Urine Acidification After Ammonium Chloride
Jayme E. Locke, MD, MPH  American Journal of Kidney Diseases 
Evaluation of the Potential Living Kidney Donor
Hai-yan Wang, MD, American Journal of Kidney Diseases
Focusing on Health Literacy Might Help Us Cross the Quality Chasm
Daniel E. Weiner, MD, MS  American Journal of Kidney Diseases 
Salt and Hypertension American Journal of Kidney Diseases
Quiz Page July 2007 American Journal of Kidney Diseases
Guidelines for the Older Adult With CKD
Karl D. Nolph, MD, American Journal of Kidney Diseases
Joseph A. Vassalotti, MD, Lesley A. Stevens, MD, MS, Andrew S
Iva Gunnarsson, MD, PhD  American Journal of Kidney Diseases 
Hemoglobin Level and Transfusions in Patients on Maintenance Dialysis: Where the Rubber Meets the Road  Eduardo Lacson, MD, MPH, Franklin Maddux, MD 
David C. Mendelssohn, MD, FRCPC, Jay B. Wish, MD 
Proteinuria and Other Urinary Biomarkers in Kidney Transplantation: Why Are We Still Waiting for Godot?  Bertram L. Kasiske, MD  American Journal of Kidney.
Usability Testing and Acceptance of an Electronic Medication Inquiry System for CKD Patients  Clarissa J. Diamantidis, MD, MHS, Marni Zuckerman, MA, Wanda.
Julie A. Wright Nunes, MD, MPH, Kerri L
IgA Nephropathy: Progress Before and Since Berger
Hypertension in the hemodialysis patient and the “lag phenomenon”: insights into pathophysiology and clinical management  Uday M Khosla, MD, Richard J.
Elevated Fibroblast Growth Factor 23 in a Patient With Metastatic Prostate Cancer and Hypophosphatemia  Casey L. Cotant, MD, Panduranga S. Rao, MD, DNB,
A Decade After the KDOQI CKD Guidelines: A Perspective From Mexico
Salicylate Intoxication as a Cause of Pseudohyperchloremia
American Journal of Kidney Diseases
Quiz Page April 2008 American Journal of Kidney Diseases
Study Designs in Patient-Oriented Research
Shirley J. Dopson, DO, Subramoniam Jayakumar, MD, Juan Carlos Q
Drug Dose Adjustments in Patients With Renal Impairment
Daniel T. Lackland, DrPH, David J.P. Barker, MD, PhD 
Erratum American Journal of Kidney Diseases
Sulfamethoxazole Crystalluria
Quiz Page August 2007 American Journal of Kidney Diseases
Risk for Incident Renal Dialysis in a Managed Care Population
Long-term Outcomes of Acute Kidney Injury: The Power and Pitfalls of Observational/Population-Based Studies  Charuhas V. Thakar, MD  American Journal.
Arnold S. Relman, MD, American Journal of Kidney Diseases
Lesley A. Stevens, MD, MS, Josef Coresh, MD, PhD, Andrew S. Levey, MD 
Trial Quality in Nephrology: How Are We Measuring Up?
Removal of Dabigatran by Hemodialysis
Multidrug-Resistant Organisms Within the Dialysis Population: A Potentially Preventable Perfect Storm  David P. Calfee, MD, MS  American Journal of Kidney.
Making Music American Journal of Kidney Diseases
Erratum American Journal of Kidney Diseases
Kidney Failure Treatment: The Freedom to Choose
Hypertension and CKD: Kidney Early Evaluation Program (KEEP) and National Health and Nutrition Examination Survey (NHANES),   Madhav V. Rao,
In the Literature: Cognitive Impairment in Hemodialysis Patients
Achieving Fairness in Access to Kidney Transplant: A Work in Progress
Increased Urinary Albumin Excretion Following Recovery From Thrombotic Thrombocytopenic Purpura Due to Acquired ADAMTS13 Deficiency  Dustin J. Little,
Quiz Page June 2009 American Journal of Kidney Diseases
MicroRNAs: A Macroview Into Focal Segmental Glomerulosclerosis
Jordi Goldstein-Fuchs, DSc, RD, RN, Denis Fouque, MD, PhD 
This Month in AJKD American Journal of Kidney Diseases
American Journal of Kidney Diseases
Dialysis Research and N-of-1 Trials: Made for Each Other?
Quiz Page January 2010 American Journal of Kidney Diseases
Clinical Practice Recommendations For Peritoneal Dialysis Adequacy
Clinical Practice Guidelines for Peritoneal Dialysis Adequacy
Quiz page December 2003 American Journal of Kidney Diseases
Medication Adherence Behavior and Priorities Among Older Adults With CKD: A Semistructured Interview Study  Dena E. Rifkin, MD, MS, M. Barton Laws, PhD,
Presentation transcript:

Differential Expression of microRNAs in Urinary Extracellular Vesicles Obtained From Hypertensive Patients  Soon Hyo Kwon, MD, Hui Tang, PhD, Ahmed Saad, MD, John R. Woollard, MS, Amir Lerman, MD, Stephen C. Textor, MD, Lilach O. Lerman, MD, PhD  American Journal of Kidney Diseases  Volume 68, Issue 2, Pages 331-332 (August 2016) DOI: 10.1053/j.ajkd.2016.01.027 Copyright © 2016 National Kidney Foundation, Inc. Terms and Conditions

Figure 1 miR levels adjusted for eGFR, systolic BP, triglycerides, HDL, and albuminuria in urinary EVs of the HV, RVH, and EH groups. Each point represents the relative miR level after normalization using Cel-miR-39. miR-21, -93, and -200b levels were lower in EH vs both HVs and RVH, whereas miR-92a level was lower vs HVs alone. ∗P<0.05 vs HVs and RVH; #P<0.05 vs HVs. American Journal of Kidney Diseases 2016 68, 331-332DOI: (10.1053/j.ajkd.2016.01.027) Copyright © 2016 National Kidney Foundation, Inc. Terms and Conditions